MYGN (STOCKS)
Myriad Genetics Inc
$4.889200
-0.190800 (-3.76%)
Prev close: $5.080000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Samraat S Raha
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $450.69M
- Employees
- 2,700
- P/E (TTM)
- -1.12
- P/B (TTM)
- 1.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
3
Buy
9
Hold
3
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.00 | $-0.01 | +0.0080 | +100.00% |
|
Jun 2025 (Q2)
|
$0.05 | $-0.01 | +0.0595 | +626.32% |
|
Mar 2025 (Q1)
|
$-0.03 | $-0.06 | +0.0298 | +49.83% |
|
Dec 2024 (Q4)
|
$0.03 | $0.03 | -0.0009 | -2.91% |
Financial Statements
| Revenues | $825.30M |
| Benefits Costs and Expenses | $1.25B |
| Cost Of Revenue | $244.60M |
| Costs And Expenses | $1.25B |
| Gross Profit | $580.70M |
| Nonoperating Income/Loss | -$4.80M |
| Operating Expenses | $1.00B |
| Depreciation and Amortization | $55.90M |
| Research and Development | $113.50M |
| Other Operating Expenses | $858.50M |
| Operating Income/Loss | -$420.50M |
| Income/Loss From Continuing Operations After Tax | -$400.50M |
| Income/Loss From Continuing Operations Before Tax | -$425.30M |
| Income Tax Expense/Benefit | -$24.80M |
| Net Income/Loss | -$400.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$400.50M |
| Net Income/Loss Available To Common Stockholders, Basic | -$400.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.35 |
| Diluted Earnings Per Share | -$4.35 |
| Basic Average Shares | 92,400,000 |
| Diluted Average Shares | 92,400,000 |
| Assets | $728.10M |
| Current Assets | $344.80M |
| Inventory | $31.60M |
| Other Current Assets | $313.20M |
| Noncurrent Assets | $383.30M |
| Fixed Assets | $111.40M |
| Intangible Assets | $163.10M |
| Other Non-current Assets | $108.80M |
| Liabilities | $355.30M |
| Current Liabilities | $148.00M |
| Accounts Payable | $31.80M |
| Wages | $47.30M |
| Other Current Liabilities | $68.90M |
| Noncurrent Liabilities | $207.30M |
| Long-term Debt | $119.50M |
| Other Non-current Liabilities | $87.80M |
| Equity | $372.80M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $372.80M |
| Liabilities And Equity | $728.10M |
| Net Cash Flow From Operating Activities | -$2.20M |
| Net Cash Flow From Operating Activities, Continuing | -$2.20M |
| Net Cash Flow From Investing Activities | -$27.30M |
| Net Cash Flow From Investing Activities, Continuing | -$27.30M |
| Net Cash Flow From Financing Activities | $74.50M |
| Net Cash Flow From Financing Activities, Continuing | $74.50M |
| Exchange Gains/Losses | $0.00 |
| Net Cash Flow | $45.00M |
| Net Cash Flow, Continuing | $45.00M |
| Comprehensive Income/Loss | -$400.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$400.60M |
| Other Comprehensive Income/Loss | -$400.60M |